The views and opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC.
An expert response from Dr. James Januzzi.
Dr. Salim Virani reviews the Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes.
An ACC.14 session presentation on the Understanding the Universal Definition of MI by Dr. David Morrow.
Drs. Mora, Harada, and Akinkoulie evaluate the pros and cons of standard lipid testing and alternative measures in the context of CVD risk.
Which laboratory test is reasonable and can help guide further management of this patient's CV risk?
Interact and share with your colleagues biomarker topics that are relevant to you and your practice.
Twelve–Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a): Prospective 15-Year Outcomes in the Bruneck Study
Circulating Omega-6 Polyunsaturated Fatty Acids and Total and Cause-Specific Mortality: The Cardiovascular Health Study
© 2014 American College of Cardiology Foundation. Visit Cardiosource.
Terms & Conditions
Registered User Agreement
Advertising and Sponsorship Policy